Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.82%278.38M | -6.17%280.03M | -3.51%287.76M | 4.52%1.22B | -3.10%298.72M | -1.00%319.3M | 8.04%298.43M | 16.78%298.24M | -12.06%1.16B | 12.79%308.27M |
| Cost of revenue | -15.32%245.8M | -6.68%250.93M | -2.24%258.48M | 5.20%1.09B | -0.51%271.4M | 0.82%290.27M | 8.37%268.9M | 15.11%264.39M | -11.30%1.04B | 13.54%272.79M |
| Gross profit | 12.24%32.59M | -1.46%29.1M | -13.49%29.28M | -1.14%122.51M | -23.02%27.32M | -16.18%29.03M | 5.12%29.53M | 31.69%33.85M | -17.97%123.92M | 7.38%35.48M |
| Operating expense | 0.49%22.76M | 1.11%20.91M | -8.09%22.39M | 26.91%88.27M | 11.51%21.57M | -5.49%22.65M | 1.75%20.68M | 16.30%24.36M | -16.21%69.55M | -12.30%19.34M |
| Selling and administrative expenses | 4.35%22.5M | 0.76%20.79M | -10.39%20.8M | 5.83%88.04M | 1.14%20.48M | -8.07%21.56M | 1.85%20.63M | 20.71%23.21M | -0.54%83.19M | -16.72%20.25M |
| -Selling and marketing expense | 15.09%4.96M | -7.21%4.24M | -19.28%4.32M | 7.19%20.18M | 320.94%4.4M | -36.49%4.31M | -21.85%4.57M | 3.97%5.35M | -22.58%18.82M | -88.31%1.05M |
| -General and administrative expense | 1.67%17.55M | 3.03%16.54M | -7.72%16.49M | 5.44%67.86M | -16.28%16.08M | 3.49%17.26M | 11.48%16.06M | 26.83%17.87M | 8.49%64.37M | 25.00%19.2M |
| Other operating expenses | -76.10%260K | 148.00%124K | 38.39%1.59M | 183.06%3.93M | --1.09M | 112.50%1.09M | -27.54%50K | -33.22%1.15M | -80.24%1.39M | ---- |
| Total other operating income | ---- | ---- | ---- | -75.37%3.7M | ---- | ---- | ---- | ---- | 96.19%15.02M | --910K |
| Operating profit | 53.96%9.83M | -7.47%8.19M | -27.34%6.9M | -37.02%34.24M | -64.38%5.75M | -40.18%6.38M | 13.95%8.85M | 99.41%9.49M | -20.11%54.37M | 46.88%16.15M |
| Net non-operating interest income (expenses) | -6.75%-2.39M | -15.95%-2.41M | -48.68%-2.92M | -25.64%-8.11M | -27.35%-2.42M | -34.52%-2.24M | -3.58%-2.08M | -7.21%-1.96M | 3.49%-6.45M | -104.85%-1.9M |
| Non-operating interest income | ---- | ---- | ---- | 22.59%1.17M | ---- | ---- | ---- | ---- | 34.46%956K | ---- |
| Non-operating interest expense | 6.75%2.39M | 15.95%2.41M | 48.68%2.92M | 25.25%9.28M | 27.35%2.42M | 34.52%2.24M | 3.58%2.08M | 7.21%1.96M | 0.16%7.41M | 15.99%1.9M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 250.44%396K | 128.46%113K | ||||||||
| Less:Write off | ---- | ---- | ---- | -250.44%-396K | ---- | ---- | ---- | ---- | -128.46%-113K | ---- |
| Other non-operating income (expenses) | -105.67%-209K | 37.85%1.85M | 23.41%1.98M | -68.27%5.11M | -130.19%-1.52M | 9.74%3.68M | -37.08%1.34M | -71.24%1.6M | 16.09M | 5.03M |
| Income before tax | -7.65%7.23M | -5.98%7.63M | -34.79%5.95M | -44.76%26.53M | -90.61%1.81M | -36.68%7.83M | 2.80%8.11M | 7.44%9.13M | -21.23%48.03M | 1,062.94%19.28M |
| Income tax | 53.19%2.35M | 0.00%1.95M | -15.63%1.75M | -48.20%6.58M | -84.69%954K | -41.54%1.53M | 3.34%1.95M | 5.98%2.07M | -18.40%12.7M | 200.48%6.23M |
| Net income | -22.48%4.88M | -7.87%5.68M | -40.41%4.21M | -43.53%19.95M | -93.44%856K | -35.37%6.29M | 2.63%6.16M | 7.87%7.06M | -22.20%35.33M | 420.07%13.05M |
| Net income continuous operations | -22.48%4.88M | -7.87%5.68M | -40.41%4.21M | -43.53%19.95M | -93.44%856K | -35.37%6.29M | 2.63%6.16M | 7.87%7.06M | -22.20%35.33M | 420.07%13.05M |
| Noncontrolling interests | -43.80%349K | -40.83%655K | -79.73%195K | -46.13%2.48M | -113.58%-372K | -50.12%621K | 81.48%1.11M | 13,642.86%962K | 41.56%4.6M | 240.80%2.74M |
| Net income attributable to the company | -20.15%4.53M | -0.65%5.02M | -34.21%4.01M | -43.14%17.47M | -88.08%1.23M | -33.20%5.67M | -6.28%5.06M | -6.73%6.1M | -27.12%30.73M | 583.85%10.31M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -20.15%4.53M | -0.65%5.02M | -34.21%4.01M | -43.14%17.47M | -88.08%1.23M | -33.20%5.67M | -6.28%5.06M | -6.73%6.1M | -27.12%30.73M | 583.85%10.31M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -20.19%0.0083 | -1.08%0.0092 | -33.93%0.0074 | -43.19%0.0321 | -87.83%0.0023 | -33.33%0.0104 | -6.06%0.0093 | -6.67%0.0112 | -27.10%0.0565 | 584.62%0.0189 |
| Diluted earnings per share | -20.19%0.0083 | -1.08%0.0092 | -33.93%0.0074 | -43.19%0.0321 | -87.83%0.0023 | -33.33%0.0104 | -6.06%0.0093 | -6.67%0.0112 | -27.10%0.0565 | 584.62%0.0189 |
| Dividend per share | 60.00%0.008 | 0 | 0.00%0.008 | -18.18%0.018 | -16.67%0.005 | 0.00%0.005 | 0 | 33.33%0.008 | -46.34%0.022 | 0.00%0.006 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.